At Lumeos Pharma AI & Regulatory, we believe that artificial intelligence should enhance human expertise—not replace it.
As an executive advisory firm serving the life sciences industry, we recognise both the opportunities and responsibilities that accompany the use of AI. We are committed to promoting responsible, ethical and transparent AI practices in our own operations and in the advice we provide to clients.
Our Principles
Our approach to AI is guided by the following principles:
Human Oversight
AI supports our work but does not replace professional judgement. All client deliverables are reviewed and validated by experienced professionals before they are issued.
Confidentiality and Data Protection
We take appropriate measures to protect confidential and personal information. We do not knowingly input client confidential information into public AI tools without appropriate safeguards and authorisation.
Transparency
Where AI tools materially assist in the development of client deliverables, we remain accountable for the accuracy, quality and professional integrity of the final work product.
Responsible Innovation
We encourage the responsible adoption of AI technologies that improve efficiency, decision-making and business outcomes while managing regulatory, ethical and operational risks.
Continuous Learning
AI technologies continue to evolve rapidly. We regularly review emerging regulatory developments, industry standards and leading practices to ensure our advisory services remain relevant and responsible.
Our Commitment
Responsible AI is one of the core capabilities of Lumeos. We are committed to helping organisations adopt AI confidently, responsibly and in alignment with applicable regulations, governance frameworks and industry best practices.